SOLVD Health is a Carlsbad precision medicine company on Faraday Avenue developing predictive diagnostic tools that identify disease risk before clinical symptoms emerge, with a primary focus on colorectal cancer interception. The LifeKit Prevent Colorectal Neoplasia Test — developed through subsidiary Metabiomics and granted FDA Breakthrough Device designation in 2019 — uses MultiTag DNA sequencing to analyze gut microbial biomarkers in stool samples, detecting precancerous adenomas and early-stage carcinomas that conventional screening often misses, a preventive approach relevant to the elderly populations served by Bayshire Carlsbad. Founded in 2014 as Prescient Medicine Holdings and rebranded in 2020, the privately held company has acquired AutoGenomics and partnered with the Harvard T.H. Chan School of Public Health's Microbiome in Public Health Center to validate metagenomics-based CRC biomarker panels. Pharmacogenomics testing for opioid use disorder and polycystic ovary syndrome extends the platform beyond oncology into personalized medicine for metabolic and neurochemical conditions. CEO Keri Donaldson, MD, leads the 11-to-50-person team from the 92008 ZIP code, positioning the company within Carlsbad's Faraday Avenue biotech corridor alongside a concentration of diagnostic and therapeutic innovators that includes neighbors such as La Costa Dental Excellence in the broader La Costa healthcare ecosystem. The noninvasive LifeKit platform sequences microbial DNA and RNA biomarkers associated with specific stages of colorectal neoplasia progression, targeting the detection gap between standard fecal immunochemical tests and diagnostic colonoscopy.